Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:MYL
Tag: NASDAQ:MYL
Mylan N.V. (NASDAQ:MYL) To Pay New Hampshire $1 Million Over EpiPen...
-
August 21, 2017
0
Mylan N.V. (NASDAQ:MYL) reported earnings of $1.10 per share missing Walls...
ME Staff
-
August 9, 2017
0
Huge Debt Burden Hinders Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Mylan...
Andy Parker
-
August 7, 2017
0
Biotech Movers: TESARO Inc (NASDAQ:TSRO) and Mylan N.V. (NASDAQ:MYL)
-
July 14, 2017
0
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Ready To Disrupt Mylan N.V. (NASDAQ:MYL) EpiPen...
Andy Parker
-
June 20, 2017
0
Mylan N.V. (NASDAQ:MYL) Says It Disagrees With FDA Decision On Generic...
Andy Parker
-
May 11, 2017
0
Mylan N.V. (NASDAQ:MYL) Epipen Still Effective After 29 Months Post Expiration
-
May 10, 2017
0
Mylan N.V. (NASDAQ:MYL) Is Served With A Warning Letter Over Integrity...
Andy Parker
-
April 12, 2017
0
Mylan N.V. (NASDAQ:MYL) Given Go-Ahead For Angiomax In Blow To Medicines...
Andy Parker
-
April 7, 2017
0
Advair Generic Developed By Mylan NV (NASDAQ:MYL) Rejected By The FDA
-
March 30, 2017
0
1
2
3
4
Page 2 of 4
